Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 163 entries
Sorted by: Best Match Show Resources per page
A quasi-experimental study of a movement and preliteracy program for 3-and 4-year-old children

quasi-experimental designs

Bedard C, Bremer E, Campbell W, Cairney J.
GSID: U4B3sJhSa7sJ
C Bedard, E Bremer, W Campbell, J Cairney - Frontiers in pediatrics, 2017 - frontiersin.org

… Design A quasi-experimental study design was used to evaluate the program. All children were assessed twice approximately 10–12 weeks apart: children in the experimental group were assessed pre- and post-program; children in the control group were assessed at...

Cite
Bedard, C., Bremer, E., Campbell, W., & Cairney, J. (2017). A quasi-experimental study of a movement and preliteracy program for 3-and 4-year-old children. Frontiers in pediatrics, 5, 94.
Bedard, Chloe, et al. "A quasi-experimental study of a movement and preliteracy program for 3-and 4-year-old children." Frontiers in pediatrics 5 (2017): 94.
Copy Download .nbib Format: MLA
Curing kinetics and morphology of a nanovesicular epoxy/stearyl-block-poly(ethylene oxide) surfactant system.

Soft matter

Bogaerts K, Lavrenova A, Spoelstra AB, Boyard N, Goderis B.
PMID: 26144526
Soft Matter. 2015 Aug 21;11(31):6212-22. doi: 10.1039/c5sm01051a.

Brittle epoxy based thermosets can be made tougher by introducing structural inhomogeneities at the micro- or nanoscale. In that respect, nano vesicles and worm-like micelles from self-assembling blockcopolymers have been shown to be very effective. This paper describes the...

Cite
Bogaerts K, Lavrenova A, Spoelstra AB, et al. Curing kinetics and morphology of a nanovesicular epoxy/stearyl-block-poly(ethylene oxide) surfactant system. Soft Matter. 2015;11(31):6212-22doi: 10.1039/c5sm01051a.
Bogaerts, K., Lavrenova, A., Spoelstra, A. B., Boyard, N., & Goderis, B. (2015). Curing kinetics and morphology of a nanovesicular epoxy/stearyl-block-poly(ethylene oxide) surfactant system. Soft matter, 11(31), 6212-22. https://doi.org/10.1039/c5sm01051a
Bogaerts, K, et al. "Curing kinetics and morphology of a nanovesicular epoxy/stearyl-block-poly(ethylene oxide) surfactant system." Soft matter vol. 11,31 (2015): 6212-22. doi: https://doi.org/10.1039/c5sm01051a
Bogaerts K, Lavrenova A, Spoelstra AB, Boyard N, Goderis B. Curing kinetics and morphology of a nanovesicular epoxy/stearyl-block-poly(ethylene oxide) surfactant system. Soft Matter. 2015 Aug 21;11(31):6212-22. doi: 10.1039/c5sm01051a. PMID: 26144526.
Copy Download .nbib Format: NLM
Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout.

Journal of pharmacy practice

Huneycutt E, Board C, Clements JN.
PMID: 28980503
J Pharm Pract. 2017 Jan 01;897190017734427. doi: 10.1177/0897190017734427. Epub 2017 Jan 01.

OBJECTIVE: To review the pharmacokinetics, clinical efficacy, safety, and role of lesinurad for the management of hyperuricemia associated with gout.DATA SELECTION: A MEDLINE search (2000 to April 2017) was conducted using the terms hyperuricemia, gout, URAT-1, URAT-1 transporter, and...

Cite
Huneycutt E, Board C, Clements JN. Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout. J Pharm Pract. 2017;897190017734427doi: 10.1177/0897190017734427.
Huneycutt, E., Board, C., & Clements, J. N. (2017). Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout. Journal of pharmacy practice, 897190017734427. https://doi.org/10.1177/0897190017734427
Huneycutt, Emily, et al. "Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout." Journal of pharmacy practice vol. (2017): 897190017734427. doi: https://doi.org/10.1177/0897190017734427
Huneycutt E, Board C, Clements JN. Lesinurad, a Selective URAT-1 Inhibitor With a Novel Mechanism in Combination With a Xanthine Oxidase Inhibitor, for Hyperuricemia Associated With Gout. J Pharm Pract. 2017 Jan 01;897190017734427. doi: 10.1177/0897190017734427. Epub 2017 Jan 01. PMID: 28980503.
Copy Download .nbib Format: NLM
Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy.

Frontiers in aging neuroscience

Lyons BE, Austin D, Seelye A, Petersen J, Yeargers J, Riley T, Sharma N, Mattek N, Dodge H, Wild K, Kaye JA.
PMID: 26696884
Front Aging Neurosci. 2015 Dec 11;7:232. doi: 10.3389/fnagi.2015.00232. eCollection 2015.

[This corrects the article on p. 102 in vol. 7, PMID: 26113819.].

Cite
Lyons BE, Austin D, Seelye A, et al. Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy. Front Aging Neurosci. 2015;7:232doi: 10.3389/fnagi.2015.00232.
Lyons, B. E., Austin, D., Seelye, A., Petersen, J., Yeargers, J., Riley, T., Sharma, N., Mattek, N., Dodge, H., Wild, K., & Kaye, J. A. (2015). Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy. Frontiers in aging neuroscience, 7232. https://doi.org/10.3389/fnagi.2015.00232
Lyons, Bayard E, et al. "Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy." Frontiers in aging neuroscience vol. 7 (2015): 232. doi: https://doi.org/10.3389/fnagi.2015.00232
Lyons BE, Austin D, Seelye A, Petersen J, Yeargers J, Riley T, Sharma N, Mattek N, Dodge H, Wild K, Kaye JA. Corrigendum: Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy. Front Aging Neurosci. 2015 Dec 11;7:232. doi: 10.3389/fnagi.2015.00232. eCollection 2015. PMID: 26696884; PMCID: PMC4675995.
Copy Download .nbib Format: NLM
Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density.

American journal of translational research

Patel SJ, Darie CC, Clarkson BD.
PMID: 27725845
Am J Transl Res. 2016 Sep 15;8(9):3614-3629. eCollection 2016.

Tumors contain heterogeneous cell populations and achieve dominance by functioning as collective systems. The mechanisms underlying the aberrant growth and interactions between cells are not very well understood. The pre-B acute lymphoblastic leukemia cells we studied were obtained directly...

Cite
Patel SJ, Darie CC, Clarkson BD. Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density. Am J Transl Res. 2016;8(9):3614-3629
Patel, S. J., Darie, C. C., & Clarkson, B. D. (2016). Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density. American journal of translational research, 8(9), 3614-3629.
Patel, Sapan J, et al. "Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density." American journal of translational research vol. 8,9 (2016): 3614-3629.
Patel SJ, Darie CC, Clarkson BD. Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density. Am J Transl Res. 2016 Sep 15;8(9):3614-3629. eCollection 2016. PMID: 27725845; PMCID: PMC5040663.
Copy Download .nbib Format: NLM
Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome).

Case reports in dermatology

Mangana J, Guenova E, Kerl K, Urosevic-Maiwald M, Amann VC, Bayard C, Dummer R, French LE.
PMID: 28611626
Case Rep Dermatol. 2017 Mar 21;9(1):74-79. doi: 10.1159/000458752. eCollection 2017.

Angioimmunoblastic T-cell lymphoma (AITCL) is a rare, aggressive lymphoma which derives from follicular helper T cells, commonly affecting the elderly population. It accounts for 2% of all non-Hodgkin lymphomas, with a reported 5-year overall survival rate of less than...

Cite
Mangana J, Guenova E, Kerl K, et al. Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome). Case Rep Dermatol. 2017;9(1):74-79doi: 10.1159/000458752.
Mangana, J., Guenova, E., Kerl, K., Urosevic-Maiwald, M., Amann, V. C., Bayard, C., Dummer, R., & French, L. E. (2017). Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome). Case reports in dermatology, 9(1), 74-79. https://doi.org/10.1159/000458752
Mangana, Joanna, et al. "Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome)." Case reports in dermatology vol. 9,1 (2017): 74-79. doi: https://doi.org/10.1159/000458752
Mangana J, Guenova E, Kerl K, Urosevic-Maiwald M, Amann VC, Bayard C, Dummer R, French LE. Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome). Case Rep Dermatol. 2017 Mar 21;9(1):74-79. doi: 10.1159/000458752. eCollection 2017. PMID: 28611626; PMCID: PMC5465657.
Copy Download .nbib Format: NLM
How do physical-chemical parameters influence the catalytic hydrogenation of 1,3-cyclohexadiene in ionic liquids?.

The journal of physical chemistry. B

Campbell PS, Podgorsek A, Gutel T, Santini CC, Pádua AA, Costa Gomes MF, Bayard F, Fenet B, Chauvin Y.
PMID: 20504005
J Phys Chem B. 2010 Jun 24;114(24):8156-65. doi: 10.1021/jp102941n.

The catalytic hydrogenation of 1,3-cyclohexadiene using [Rh(COD)(PPh(3))(2)]NTf(2) (COD = 1,5-cyclooctadiene) was performed in two ionic liquids: 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide, [C(1)C(4)Im][NTf(2)], and 1-butyl-2,3-dimethylimidazolium bis(trifluoromethylsulfonyl)imide, [C(1)C(1)C(4)Im][NTf(2)]. It is observed that the reaction is twice as fast in [C(1)C(4)Im][NTf(2)] than in [C(1)C(1)C(4)Im][NTf(2)]. To...

Cite
Campbell PS, Podgorsek A, Gutel T, et al. How do physical-chemical parameters influence the catalytic hydrogenation of 1,3-cyclohexadiene in ionic liquids?. J Phys Chem B. 2010;114(24):8156-65doi: 10.1021/jp102941n.
Campbell, P. S., Podgorsek, A., Gutel, T., Santini, C. C., Pádua, A. A., Costa Gomes, M. F., Bayard, F., Fenet, B., & Chauvin, Y. (2010). How do physical-chemical parameters influence the catalytic hydrogenation of 1,3-cyclohexadiene in ionic liquids?. The journal of physical chemistry. B, 114(24), 8156-65. https://doi.org/10.1021/jp102941n
Campbell, Paul S, et al. "How do physical-chemical parameters influence the catalytic hydrogenation of 1,3-cyclohexadiene in ionic liquids?." The journal of physical chemistry. B vol. 114,24 (2010): 8156-65. doi: https://doi.org/10.1021/jp102941n
Campbell PS, Podgorsek A, Gutel T, Santini CC, Pádua AA, Costa Gomes MF, Bayard F, Fenet B, Chauvin Y. How do physical-chemical parameters influence the catalytic hydrogenation of 1,3-cyclohexadiene in ionic liquids?. J Phys Chem B. 2010 Jun 24;114(24):8156-65. doi: 10.1021/jp102941n. PMID: 20504005.
Copy Download .nbib Format: NLM
Toward DNA-based Security Circuitry: First Step - Random Number Generation.

The ... Midwest Symposium on Circuits and Systems conference proceedings : MWSCAS. Midwest Symposium on Circuits and Systems

Bogard CM, Arazi B, Rouchka EC.
PMID: 20436783
Conf Proc (Midwest Symp Circuits Syst). 2008 Aug 10;51:597-600. doi: 10.1109/MWSCAS.2008.4616870.

DNA-based circuit design is an area of research in which traditional silicon-based technologies are replaced by naturally occurring phenomena taken from biochemistry and molecular biology. Our team investigates the implications of DNA-based circuit design in serving security applications. As...

Cite
Bogard CM, Arazi B, Rouchka EC. Toward DNA-based Security Circuitry: First Step - Random Number Generation. Conf Proc (Midwest Symp Circuits Syst). 2008;51:597-600doi: 10.1109/MWSCAS.2008.4616870.
Bogard, C. M., Arazi, B., & Rouchka, E. C. (2008). Toward DNA-based Security Circuitry: First Step - Random Number Generation. The ... Midwest Symposium on Circuits and Systems conference proceedings : MWSCAS. Midwest Symposium on Circuits and Systems, 51597-600. https://doi.org/10.1109/MWSCAS.2008.4616870
Bogard, Christy M, et al. "Toward DNA-based Security Circuitry: First Step - Random Number Generation." The ... Midwest Symposium on Circuits and Systems conference proceedings : MWSCAS. Midwest Symposium on Circuits and Systems vol. 51 (2008): 597-600. doi: https://doi.org/10.1109/MWSCAS.2008.4616870
Bogard CM, Arazi B, Rouchka EC. Toward DNA-based Security Circuitry: First Step - Random Number Generation. Conf Proc (Midwest Symp Circuits Syst). 2008 Aug 10;51:597-600. doi: 10.1109/MWSCAS.2008.4616870. PMID: 20436783; PMCID: PMC2861576.
Copy Download .nbib Format: NLM
Deciphering reward-based decision-making in schizophrenia: A meta-analysis and behavioral modeling of the Iowa Gambling Task.

Schizophrenia research

Betz LT, Brambilla P, Ilankovic A, Premkumar P, Kim MS, Raffard S, Bayard S, Hori H, Lee KU, Lee SJ, Koutsouleris N, Kambeitz J.
PMID: 30262254
Schizophr Res. 2019 Feb;204:7-15. doi: 10.1016/j.schres.2018.09.009. Epub 2018 Sep 25.

BACKGROUND: Patients with schizophrenia (SZP) have been reported to exhibit impairments in reward-based decision-making, but results are heterogeneous with multiple potential confounds such as age, intelligence level, clinical symptoms or medication, making it difficult to evaluate the robustness of...

Cite
Betz LT, Brambilla P, Ilankovic A, et al. Deciphering reward-based decision-making in schizophrenia: A meta-analysis and behavioral modeling of the Iowa Gambling Task. Schizophr Res. 2018;204:7-15doi: 10.1016/j.schres.2018.09.009.
Betz, L. T., Brambilla, P., Ilankovic, A., Premkumar, P., Kim, M. S., Raffard, S., Bayard, S., Hori, H., Lee, K. U., Lee, S. J., Koutsouleris, N., & Kambeitz, J. (2019). Deciphering reward-based decision-making in schizophrenia: A meta-analysis and behavioral modeling of the Iowa Gambling Task. Schizophrenia research, 2047-15. https://doi.org/10.1016/j.schres.2018.09.009
Betz, Linda T, et al. "Deciphering reward-based decision-making in schizophrenia: A meta-analysis and behavioral modeling of the Iowa Gambling Task." Schizophrenia research vol. 204 (2019): 7-15. doi: https://doi.org/10.1016/j.schres.2018.09.009
Betz LT, Brambilla P, Ilankovic A, Premkumar P, Kim MS, Raffard S, Bayard S, Hori H, Lee KU, Lee SJ, Koutsouleris N, Kambeitz J. Deciphering reward-based decision-making in schizophrenia: A meta-analysis and behavioral modeling of the Iowa Gambling Task. Schizophr Res. 2019 Feb;204:7-15. doi: 10.1016/j.schres.2018.09.009. Epub 2018 Sep 25. PMID: 30262254.
Copy Download .nbib Format: NLM
Retropharyngeal Steroid Use in Anterior Cervical Discectomy and Fusion.

Clinical spine surgery

Robinson WA, Carlson BC, Freedman BA, Sebastian AS.
PMID: 29794533
Clin Spine Surg. 2019 Feb;32(1):1-3. doi: 10.1097/BSD.0000000000000653.

No abstract available.

Cite
Robinson WA, Carlson BC, Freedman BA, et al. Retropharyngeal Steroid Use in Anterior Cervical Discectomy and Fusion. Clin Spine Surg. 2019;32(1):1-3doi: 10.1097/BSD.0000000000000653.
Robinson, W. A., Carlson, B. C., Freedman, B. A., & Sebastian, A. S. (2019). Retropharyngeal Steroid Use in Anterior Cervical Discectomy and Fusion. Clinical spine surgery, 32(1), 1-3. https://doi.org/10.1097/BSD.0000000000000653
Robinson, William A, et al. "Retropharyngeal Steroid Use in Anterior Cervical Discectomy and Fusion." Clinical spine surgery vol. 32,1 (2019): 1-3. doi: https://doi.org/10.1097/BSD.0000000000000653
Robinson WA, Carlson BC, Freedman BA, Sebastian AS. Retropharyngeal Steroid Use in Anterior Cervical Discectomy and Fusion. Clin Spine Surg. 2019 Feb;32(1):1-3. doi: 10.1097/BSD.0000000000000653. PMID: 29794533.
Copy Download .nbib Format: NLM
Crystallization of emulsified anhydrous milk fat: The role of confinement and of minor compounds. A DSC study.

Food chemistry

Bayard M, Cansell M, Leal-Calderon F.
PMID: 34823932
Food Chem. 2021 Nov 14;131605. doi: 10.1016/j.foodchem.2021.131605. Epub 2021 Nov 14.

We examined the crystallization and melting of anhydrous milk fat (AMF)-in-water emulsions stabilized by sodium caseinate. Various additives at low concentrations (

Cite
Bayard M, Cansell M, Leal-Calderon F. Crystallization of emulsified anhydrous milk fat: The role of confinement and of minor compounds. A DSC study. Food Chem. 2021;131605doi: 10.1016/j.foodchem.2021.131605.
Bayard, M., Cansell, M., & Leal-Calderon, F. (2021). Crystallization of emulsified anhydrous milk fat: The role of confinement and of minor compounds. A DSC study. Food chemistry, 131605. https://doi.org/10.1016/j.foodchem.2021.131605
Bayard, Mathilde, et al. "Crystallization of emulsified anhydrous milk fat: The role of confinement and of minor compounds. A DSC study." Food chemistry vol. (2021): 131605. doi: https://doi.org/10.1016/j.foodchem.2021.131605
Bayard M, Cansell M, Leal-Calderon F. Crystallization of emulsified anhydrous milk fat: The role of confinement and of minor compounds. A DSC study. Food Chem. 2021 Nov 14;131605. doi: 10.1016/j.foodchem.2021.131605. Epub 2021 Nov 14. PMID: 34823932.
Copy Download .nbib Format: NLM
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.

Journal of hematology & oncology

Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z.
PMID: 35012610
J Hematol Oncol. 2022 Jan 10;15(1):5. doi: 10.1186/s13045-021-01222-y.

BACKGROUND: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) through direct lysis of infected lung epithelial cells, which releases damage-associated molecular patterns and induces a pro-inflammatory cytokine milieu causing systemic inflammation. Anti-viral and anti-inflammatory agents...

Cite
Song NJ, Allen C, Vilgelm AE, et al. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology. J Hematol Oncol. 2022;15(1):5doi: 10.1186/s13045-021-01222-y.
Song, N. J., Allen, C., Vilgelm, A. E., Riesenberg, B. P., Weller, K. P., Reynolds, K., Chakravarthy, K. B., Kumar, A., Khatiwada, A., Sun, Z., Ma, A., Chang, Y., Yusuf, M., Li, A., Zeng, C., Evans, J. P., Bucci, D., Gunasena, M., Xu, M., Liyanage, N. P. M., Bolyard, C., Velegraki, M., Liu, S. L., Ma, Q., Devenport, M., Liu, Y., Zheng, P., Malvestutto, C. D., Chung, D., & Li, Z. (2022). Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology. Journal of hematology & oncology, 15(1), 5. https://doi.org/10.1186/s13045-021-01222-y
Song, No-Joon, et al. "Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology." Journal of hematology & oncology vol. 15,1 (2022): 5. doi: https://doi.org/10.1186/s13045-021-01222-y
Song NJ, Allen C, Vilgelm AE, Riesenberg BP, Weller KP, Reynolds K, Chakravarthy KB, Kumar A, Khatiwada A, Sun Z, Ma A, Chang Y, Yusuf M, Li A, Zeng C, Evans JP, Bucci D, Gunasena M, Xu M, Liyanage NPM, Bolyard C, Velegraki M, Liu SL, Ma Q, Devenport M, Liu Y, Zheng P, Malvestutto CD, Chung D, Li Z. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology. J Hematol Oncol. 2022 Jan 10;15(1):5. doi: 10.1186/s13045-021-01222-y. PMID: 35012610.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 163 entries